285
- Moustardas P, Kadoglou NP, Katsimpoulas M et al (2014) The complementary effects of
atorvastatin and exercise treatment on the composition and stability of the atherosclerotic
plaques in ApoE knockout mice. PLoS One 9(9):e108240 - Lusis AJ (2000) Atherosclerosis. Nature 407(6801):233–241
- Kolodgie FD, Burke AP, Skorija KS et al (2006) Lipoprotein-associated phospholipase A2
protein expression in the natural progression of human coronary atherosclerosis. Arterioscler
Thromb Vasc Biol 26(11):2523–2529 - Lind L, Simon T, Johansson L et al (2012) Circulating levels of secretory- and lipoprotein-
associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-
cause mortality. Eur Heart J 33(23):2946–2954 - Verona J, Gilligan LE, Gimenez C et al (2013) Physical activity and cardiometabolic risk in
male children and adolescents: the Balcarce study. Life Sci 93(2–3):64–68 - Wooten JS, Nambi P, Gillard BK et al (2013) Intensive lifestyle modification reduces
Lp-PLA2 in dyslipidemic HIV/HAART patients. Med Sci Sports Exerc 45(6):1043–1050 - Reddy KJ, Singh M, Batsell RR et al (2010) Lipoprotein-associated phospholipase A2 mass
is significantly reduced in dyslipidemic patients treated with lifestyle modification and com-
bination lipid-modifying drug therapy. Prev Cardiol 13(3):130–134 - Alpert MA (1999) Homocyst(e)ine, atherosclerosis, and thrombosis. South Med
J 92(9):858–865 - Konecky N, Malinow MR, Tunick PA et al (1997) Correlation between plasma homocyst(e)
ine and aortic atherosclerosis. Am Heart J 133(5):534–540 - XQ W, Ding J, Ge AY et al (2014) Acute phase homocysteine related to severity and outcome
of atherothrombotic stroke – reply. Eur J Intern Med 25(1):e15 - Davies EJ, Moxham T, Rees K et al (2010) Exercise training for systolic heart failure:
Cochrane systematic review and meta-analysis. Eur J Heart Fail 12(7):706–715 - Piepoli MF, Davos C, Francis DP et al (2004) Exercise training meta-analysis of trials in
patients with chronic heart failure (ExTraMATCH). BMJ 328(7433):189 - Taylor RS, Brown A, Ebrahim S et al (2004) Exercise-based rehabilitation for patients with
coronary heart disease: systematic review and meta-analysis of randomized controlled trials.
Am J Med 116(10):682–692 - Lee DC, Pate RR, Lavie CJ et al (2014) Leisure-time running reduces all-cause and cardio-
vascular mortality risk. J Am Coll Cardiol 64(5):472–481 - Kroger K, Lehmann N, Rappaport L et al (2011) Carotid and peripheral atherosclerosis in
male marathon runners. Med Sci Sports Exerc 43(7):1142–1147 - Taylor BA, Zaleski AL, Capizzi JA et al (2014) Influence of chronic exercise on carotid ath-
erosclerosis in marathon runners. BMJ Open 4(2):e004498 - Wen CP, Wai JP, Tsai MK et al (2011) Minimum amount of physical activity for reduced mor-
tality and extended life expectancy: a prospective cohort study. Lancet 378(9798):1244–1253 - Paffenbarger RS Jr, Hyde RT, Wing AL et al (1993) The association of changes in physical-
activity level and other lifestyle characteristics with mortality among men. N Engl J Med
328(8):538–545 - Sofi F, Capalbo A, Cesari F et al (2008) Physical activity during leisure time and primary
prevention of coronary heart disease: an updated meta-analysis of cohort studies. Eur
J Cardiovasc Prev Rehabil 15(3):247–257 - Sattelmair J, Pertman J, Ding EL et al (2011) Dose response between physical activity and
risk of coronary heart disease: a meta-analysis. Circulation 124(7):789–795 - Baggish AL, Wang F, Weiner RB et al (2008) Training-specific changes in cardiac struc-
ture and function: a prospective and longitudinal assessment of competitive athletes. J Appl
Physiol (1985) 104(4):1121–1128 - Kim JH, Baggish AL (2016) Differentiating exercise-induced cardiac adaptations from car-
diac pathology: the “Grey zone” of clinical uncertainty. Can J Cardiol 32(4):429–437 - Schnohr P, O'Keefe JH, Marott JL et al (2015) Dose of jogging and long-term mortality: the
Copenhagen City Heart Study. J Am Coll Cardiol 65(5):411–419
15 Physical Exercise Is a Potential “Medicine” for Atherosclerosis